NCT04479709View on ClinicalTrials.gov

The Urinary Microbiome in Patients Receiving Intradetrusor Botox Injections

CompletedOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Overactive Bladder

Trial Locations (1)

44109

MetroHealth, Cleveland

All Listed Sponsors

lead

MetroHealth Medical Center

OTHER

NCT04479709 - The Urinary Microbiome in Patients Receiving Intradetrusor Botox Injections | Biotech Hunter | Biotech Hunter